Pharmaceutical / Drug Definition :
Blocks protein synthesis by binding to domains II and V of 23S rRNA of 50S ribosomal subunit. Binding at domain II enables drug to retain activity against gram-positive cocci in resistance mediated by methylases that alter domain-V binding site
FDA Label Requirements and Exceptions
Telithromycin
FDA Import Information
Telithromycin
FDA Detentions
Telithromycin (Telithromycin Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Telithromycin (Telithromycin Suppliers)
- Processors Telithromycin
- Repackers Telithromycin
- Relabelers Telithromycin
- Exporters Telithromycin
- Importers Telithromycin
For more information about Telithromycin, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
